We are part of The Trust Project
A new proposal to revive Section 936

Experts discuss whether Puerto Rico could become the U.S. biopharmaceutical hub again due to the Coronavirus pandemic

18 de marzo de 2020 - 10:15 AM

Archival note
This content was published more than 4 years ago.
(GFR Media)
(GFR Media)

Puerto Rico is back in the federal agenda, but this time, the island appears as a possible solution to the high U.S. dependence on Chinese-made pharmaceutical products, a fact that has been exposed amid the COVID-19 pandemic.

Popular en la Comunidad


Ups...

Nuestro sitio no es visible desde este navegador.

Te invitamos a descargar cualquiera de estos navegadores para ver nuestras noticias: